Oncology Ultrasound

Cystadenomas and cystadenofibromas accounted for 46 percent of benign lesions initially scored as O-RADS 4 and 5 lesions on pelvic ultrasound, according to newly published research.

Approximately 15 percent of women with abnormal screening mammography results and adverse social determinants of health (SDOH) had follow-up diagnostic mammography or breast ultrasound within 30 days, according to multinational research presented at the Society of Breast Imaging symposium.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Providing 3D ultrasound tomographic views, the Breast Acoustic CT device has an updated configuration that reportedly improves coverage and visualization of posterior breast tissue.

In addition to significantly reduced interpretation time, researchers found that adjunctive AI with ultrasound resulted in accuracy improvements of greater than 7 percent for nodule echogenicity and 16 percent for nodule margin assessments.

In comparison to LI-RADS version 2018 for MRI assessment, the use of perfluorobutane-enhanced ultrasound incorporating Kupffer-phase findings yielded comparable sensitivity and specificity for detecting hepatocellular carcinoma (HCC) nodules < 20 mm in high-risk patients, according to new research.

In a prospective comparison with prior criteria for evaluating hepatocellular carcinoma surveillance, the American Association for the Study of Liver Diseases (AASLD) version 2023 system offered significantly higher sensitivity.

Catch up on a variety of new FDA clearances in radiology from the past week.

Offering compact versatility for an array of clinical settings, the ASUS Handheld Ultrasound LU800 is reportedly the first handheld device to be supported across Android, Chrome, iOS and Windows operating systems.

Catch up on the most well-viewed ultrasound content from 2025.

Preliminary research has shown that the Vanquish Water Vapor Ablation System eliminated MRI-visible intermediate-risk PCa in over 90 percent of patients.

The newly launched Compass AI software platform reportedly facilitates a 94 percent compliance rate for documentation of point-of-care ultrasound (POCUS) exams.

The Sonosite MT ultrasound device reportedly combines portability and enhanced high-resolution images with multiple features to promote workflow efficiency.

In a recent interview, Deepa Sheth, M.D., discussed the rising incidence of breast cancer, key considerations in supplemental imaging for women with dense breasts and use of the CIVIE RadPod platform to facilitate consistent quality and imaging reads by fellowship-trained breast radiologists.

New enhancements for the Venue POCUS devices include automated labeling of anatomical landmarks with Nerveblox to facilitate 12 common peripheral nerve blocks and contrast-enhanced ultrasound geared to abdominal injury assessments.

Catch up on the top radiology content of the past week.

For masses interpreted as BI-RADS category 4 and 5 presentations on breast ultrasound, the authors of a new study found that the presence of echogenic rind had an 81 to 85 percent specificity for malignancy.

The Voluson Performance 18 and 16 ultrasound devices reportedly combine enhanced imaging capabilities with AI-enabled efficiencies.

Catch up on the most-well viewed radiology content in August 2025.

While the research reveals key benefits with portable imaging, particularly point-of-care ultrasound applications with AI capabilities, these authors note challenges with variability in training and advocate for radiologist-led oversight.

The MyLab A50 and MyLab A70 ultrasound platforms reportedly enable a variety of detailed and multiparametric evaluations, including assessments for liver elastography and strain analysis echocardiography.

Could the NeedleVue LC1 Ultrasound System reinvent real-time ultrasound-assisted needle guidance for interventional procedures?

Researchers noted a 78 percent malignancy rate when associated architectural distortion was present on digital breast tomosynthesis (DBT) with highly suspicious masses or microcalcifications.

In addition to facilitating centralized scanning for a variety of imaging, the TechLive system may help ease the strain of technologist shortages and broaden access to advanced imaging exams.

Mammography detected 82 percent of pregnancy-associated breast cancer in a cohort of women with a high prevalence of extremely dense breasts, according to a new study.